Andera Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
T-knife Therapeutics is a biopharmaceutical company developing T cell therapies to treat cancer, with an initial focus on solid tumors.
BiotechHealthtechBerlin, DE
Elisa Kieback(Co-founder & Chief Technology Officer)inThomas Blankenstein(Scientific Founder)Thomas Soloway(Chief Executive Officer)Camille Landis(Chief Business Officer / Chief Financial Officer)inPeggy Sotiropoulou(Chief Scientific Officer)in
Co-investorsVersant VenturesEQT Life SciencesRA CapitalSixty Degree CapitalFidelity Investments
Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.
BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE
Hans Moebius(Co-founder and CMO, Head of Clinical Operations)inAnton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)in
Co-investorsCARMA FUNDDolby Family VenturesFountain Healthcare PartnersGimvLBBW Venture Capital GmbHLifeArc Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











